23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
102.14%
Revenue growth of 102.14% vs. zero growth in Insurance - Life. Walter Schloss might still want to see if it can translate into profits.
102.14%
Positive gross profit growth while Insurance - Life median is negative. Peter Lynch would see a notable competitive edge in cost or pricing.
25.79%
EBIT growth of 25.79% while Insurance - Life median is zero. Walter Schloss would see a marginal edge that could be expanded upon.
25.79%
Operating income growth of 25.79% while Insurance - Life median is zero. Walter Schloss might see a modest advantage that can expand.
48.83%
Net income growth exceeding 1.5x Insurance - Life median of 15.58%. Joel Greenblatt would check if brand strength or cost advantages fuel this outperformance.
50.61%
EPS growth exceeding 1.5x Insurance - Life median of 15.38%. Joel Greenblatt would confirm if consistent earnings expansion underpins these gains.
49.34%
Diluted EPS growth exceeding 1.5x Insurance - Life median of 15.38%. Joel Greenblatt would confirm if strong net income growth or buybacks drive outperformance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-7.94%
Negative OCF growth while Insurance - Life median is 0.00%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-7.94%
Negative FCF growth while Insurance - Life median is 0.00%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
113.49%
10Y revenue/share CAGR exceeding 1.5x Insurance - Life median of 28.92%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
-6.48%
Negative 5Y CAGR while Insurance - Life median is 0.00%. Seth Klarman would see if others are at least growing moderately, indicating a firm-specific problem.
38.58%
3Y revenue/share growth exceeding 1.5x Insurance - Life median of 6.52%. Joel Greenblatt might see a short-term competitive advantage at play.
131.20%
OCF/share CAGR exceeding 1.5x Insurance - Life median of 10.99% over 10 years. Joel Greenblatt would verify if a unique competitive moat underlies these cash flows.
-3.71%
Negative 5Y OCF/share CAGR while Insurance - Life median is 2.16%. Seth Klarman might see a firm-specific issue if peers still expand cash flow.
-12.60%
Negative 3Y OCF/share CAGR while Insurance - Life median is 0.00%. Seth Klarman would check whether it’s cyclical or a firm-specific problem.
81.29%
Net income/share CAGR exceeding 1.5x Insurance - Life median of 18.89% over a decade. Joel Greenblatt might see a standout compounder of earnings.
211.89%
Positive 5Y CAGR while Insurance - Life median is negative. Peter Lynch sees a notable advantage vs. peers struggling to grow net income/share.
82.99%
Positive 3Y CAGR while Insurance - Life median is negative. Peter Lynch sees a big short-term advantage vs. peers struggling with profit declines.
111.99%
Equity/share CAGR exceeding 1.5x Insurance - Life median of 32.49% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
31.58%
5Y equity/share CAGR of 31.58% while Insurance - Life median is zero. Walter Schloss sees a slight positive that might compound if management executes well.
10.97%
Positive short-term equity/share CAGR while Insurance - Life is negative. Peter Lynch finds a relative advantage vs. sector-level slowdown.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
11.30%
AR growth of 11.30% while Insurance - Life median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
No Data
No Data available this quarter, please select a different quarter.
1.70%
Asset growth near Insurance - Life median. Charlie Munger attributes it to a typical industry cycle of capital investment.
0.13%
Below 50% of Insurance - Life median. Jim Chanos suspects deeper issues blocking net worth accumulation.
-8.05%
Debt is shrinking while Insurance - Life median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
12.68%
SG&A growth far above Insurance - Life median. Jim Chanos sees potential red flags in cost management or diminishing returns on spending.